Αρχική World News Keeping progress in oncology on the agenda: ESMO honours recipients of its...

Keeping progress in oncology on the agenda: ESMO honours recipients of its 2020 awards

The global coronavirus pandemic has disrupted cancer research, prevention and treatment to an extent never seen before.

03 Dec 2020

LUGANO, Switzerland – The global coronavirus pandemic has disrupted cancer research, prevention and treatment to an extent never seen before. To sustain the development of medical knowledge and therapeutic progress for patients worldwide, particular attention must now be paid to the future of the discipline – and to the individuals who continue to work tirelessly to make it evolve. The European Society for Medical Oncology (ESMO) is proud to honour the 2020 recipients of its annual awards, all of whom share the Society’s commitment to advancing the field of oncology, no matter how difficult the circumstances.

In keeping with its determination to stay the course and continue driving oncology forward throughout the ongoing health crisis, ESMO maintained nominations for the awards usually presented at specialised congresses, some of which had to be cancelled in 2020. These distinctions go to the following dedicated investigators (1) and illustrious experts with major research contributions to their name:

  • Lillian L. Siu, Canada – Targeted Anticancer Therapies (TAT) 2020 Honorary Award
  • Fiona Blackhall, UK – Heine H. Hansen 2020 Award, jointly bestowed by ESMO and the International Association for the Study of Lung Cancer (IASLC)
  • Sherene Loi, Australia – ESMO Breast Cancer 2020 Award
  • Jedd D. Wolchok, USA – ESMO Award for Immuno-Oncology 2020

The ESMO Award for Immuno-Oncology, which was created in commemoration of ESMO’s founding father Georges Mathé, is of particular significance this year as it marks the 10-year anniversary of Mathé’s death. “Mathé was a pioneer of immunotherapy and visionary who paved the way for ESMO to become what it is today: the leading professional organisation for medical oncology,” said ESMO President Solange Peters. “All of this year’s winners have in common with Mathé the ambition to break new ground in their respective fields and the will to improve cancer patients’ lives,” she added. “Their successes are a worthwhile reminder that progress is possible through adversity – and ESMO prides itself on offering its unwavering support to those who make progress happen.”

On the occasion of the ESMO Virtual Congress 2020, the well-known ESMO awards were conferred to four outstanding oncology researchers and clinicians with a track record of exceptional achievements:

  • Hans-Joachim Schmoll, Germany – ESMO Award 2020
  • Nadia Harbeck, Germany – ESMO Lifetime Achievement Award 2020
  • Antoni Ribas, USA – ESMO Award for Translational Research 2020
  • Caroline Robert, France – ESMO Women for Oncology Award 2020

Notes to editors

1 The 2020 recipients of the TAT 2020 Honorary Award, the Heine H. Hansen Award, the ESMO Breast Cancer Award and the ESMO Award for Immuno-Oncology will have the opportunity to give their award lectures at the respective meetings in 2021.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...